Pages that link to "Q33745649"
Jump to navigation
Jump to search
The following pages link to Priming BCL-2 to kill: the combination therapy of tamoxifen and ABT-199 in ER+ breast cancer (Q33745649):
Displaying 5 items.
- Risk determination and prevention of breast cancer (Q26991921) (← links)
- Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy. (Q35809680) (← links)
- Bcl-2 promotes metastasis through the epithelial-to-mesenchymal transition in the BCap37 medullary breast cancer cell line. (Q55241008) (← links)
- Discovery of a small-molecule inhibitor of specific serine residue BAD phosphorylation (Q57476780) (← links)
- Pharmacological reactivation of MYC-dependent apoptosis induces susceptibility to anti-PD-1 immunotherapy (Q61798926) (← links)